GERMAN HEALTH CARE MARKET: Novartis lost its lawsuit against German Federal Joint Committee (GBA)

The request for previously authorized drugs to be reviewed by the German Federal Joint Committee (GBA) is legal, decided the Superior State Social Court (LSG Berlin-Brandenburg) February 28, 2013 under reference number: L 7 KA 106/12 KL ER. The pharmaceutical company Novartis was defeated by the Federal Joint Committee (Gemeinsamen Bundesausschuss) on the question of …

Continue reading "GERMAN HEALTH CARE MARKET: Novartis lost its lawsuit against German Federal Joint Committee (GBA)"